Kanbi  Pharma  Teknoloji  Limite
147118-36-3
147118-36-3

147118-36-3

Non pwodwi: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methanol
CAS:147118-36-3
MF: C16H20FN3O3S
MW:353.41
EINECS:604-563-9
MDL No.:MFCD08063917

Voye rechèch
Dekri teren

Spesifikasyon:

Aparans  
   

 

Aplikasyon:

4- (4-fluorofenil) -6-izopropil-2- [(N-methyl-N-methylsulfonyl) amino] pirimidin-5-metanòl se yon nouvo jenerasyon lipid statin -bese dwòg devlope pa Yoshinori Yano, Japon. Li fè pati inhibitor HMG CoA reduktaz la epi li ka diminye konsantrasyon ki wo nan kolestewòl ki ba-dansite, kolestewòl total, trigliserid, ak pwoteyin dekonzim B, pandan y ap ogmante konsantrasyon nan kolestewòl wo-dansite. Li ka itilize pou tretman konplè nan ipèkolesterolemi prensipal, maladi metabolis grès melanje, ak omozigot ipèkolesterolemi familyal. Konpare ak lòt dwòg ki bese lipid statin, rosuvastatin gen avantaj ki genyen nan efikasite definitif, itilizasyon pratik ak san danje, ak efè segondè minim, epi li ke yo rekonèt kòm "super statin".

 

Sinonim:

147118-36-3

4-(4-Fluorofenil)-6-izopropil-2-[(N-methyl-N-methylsufonyl)amino]pirimidin-5-il-metanòl

N-(4-(4-fluorofenil)-5-(idroksimetil)-6-isopropilpirimidin-2-il)-N-methylmethanesulfonamide

N-[4-({4-fluorofenil)-5-(idroksimetil)-6-propan{-2-ilpirimidin-2-il]-N-methylmethanesulfonamide

METHANEZULFONAMID, N-[4-({4-FLUOROFENYL)-5-(IDROKSIMETIL)-6-({1-METILETIL)-2-PIRIMIDINYL]-N-METHYL -


Foto pwodwi:

 

 

 

Baj popilè: 147118-36-3, Lachin 147118-36-3 manifaktirè, founisè

Inquiry
goTop

(0/10)

clearall